K-numberK243341
Device nameGenius AI Detection 2.0
ApplicantHologic, Inc.
Product codeQDQ
Device classClass II
Decision dateJul 31, 2025
DecisionSubstantially Equivalent
Regulation892.2090
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

Genius AI Detection 2.0 is a computer-aided detection and diagnosis software device that analyzes digital breast tomosynthesis (DBT) images to identify and mark suspicious lesions including masses, architectural distortions, asymmetries, and calcifications. The device provides confidence scores and a case score to aid radiologists in interpreting DBT exams in real-time concurrent reading, where the physician confirms or dismisses findings during the exam.

Technological characteristics

The subject device is functionally identical to the predicate (K221449) but adds compatibility with the Envision Mammography Platform in addition to Selenia Dimensions and 3Dimensions systems. New features include support for implant-displaced views on Selenia systems and a CC-MLO correlation algorithm for Envision cases. The Envision platform supports only high-resolution 1-mm and 6-mm smart slices, whereas Selenia supports standard and high-resolution modes.

Test standards cited

IEC 62304:2015 (Medical device software – Software Life Cycle Processes) and ISO 14971:2019 (Medical Devices – Application of Risk Management to Medical Devices).

Substantial equivalence argument

The device uses identical machine learning algorithms and mode of action as the predicate to aid detection and characterization of breast lesions. A standalone comparison study demonstrated non-inferior performance on Envision images versus Selenia images (AUC difference of -0.0017, p=0.87), with equivalent sensitivity, specificity, and false marker rates. Additional validation confirmed the CC-MLO correlation algorithm achieves 90% accuracy on malignant lesions and maintains equivalent clinical workflow, supporting the conclusion that safety and effectiveness are unchanged despite platform expansion.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →